Affinia Therapeutics
Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies intended to develop medicines for devastating diseases. The company leverages synthetic and systems biology combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases with significant unmet needs, thereby providing medical professionals with the rational design of novel vectors and gene therapies with remarkably improved properties.
Domain
affiniatx.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$40.0M
Founded
2018
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Affinia Therapeutics use?+
We have not yet detected technologies for Affinia Therapeutics.
What industry is Affinia Therapeutics in?+
Affinia Therapeutics operates in the Biotechnology industry.
Where is Affinia Therapeutics based?+
Affinia Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026